Science & Enterprise subscription

Follow us on Twitter

  • Make me wanna shout ... #BillsMafia https://t.co/iF1vhKHXtu
    about 58 mins ago
  • First of two podcasts with experiences of news photographers in the insurrection. Thanks @cherissmay for sharing yo… https://t.co/aCjPD6ct84
    about 17 hours ago
  • Half or more of American adults express negative opinions about the way Covid-19 vaccines are distributed, accordin… https://t.co/9l2SUpW85u
    about 23 hours ago
  • New post on Science and Enterprise: Infographic – US Public Down on Vaccine Rollout https://t.co/vegz3ihvIO #Science #Business
    about 23 hours ago
  • We've written several times about Lander and his work, including companies he founded. ... Biden to Elevate Science… https://t.co/rWVGTa1gPL
    about 1 day ago

Please share Science & Enterprise

Device-Aided Covid-19 Vaccine Invokes Immune Response

SARS-CoV-2 and cell

Results from an early clinical trial show a Covid-19 vaccine using an electronic device to boost uptake in cells is safe and generates an immune-system response. . . . → Read More: Device-Aided Covid-19 Vaccine Invokes Immune Response

Daily Covid-19 Nasal Spray Vaccine in Works

Nasal spray

A group of university and government labs is formulating an antiviral drug as a nasal spray for use as a daily preventive vaccine against Covid-19 infections. . . . → Read More: Daily Covid-19 Nasal Spray Vaccine in Works

DoD Funding Mobile Vaccine/Therapy Manufacturing Lab

DNAmolcule model

The U.S. Defense Department’s research agency is funding a prototype mobile lab to produce RNA-based vaccines and therapies in the field on demand. . . . → Read More: DoD Funding Mobile Vaccine/Therapy Manufacturing Lab

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

DoD Funds Covid-19 G.I. Infection Therapy

Spirulina powder

A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission. . . . → Read More: DoD Funds Covid-19 G.I. Infection Therapy

DoD Funding Variable Covid-19 Vaccine Technology

SARS-Cov-2 virus

The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

Covid-19 Antibody Therapy Prepares for Trial

Cattle

A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial. . . . → Read More: Covid-19 Antibody Therapy Prepares for Trial

Small Biz Grant Funds PTSD Diagnostic, Treatment

Road-side bomb

A company creating diagnostics and a treatment for post-traumatic stress disorder, or PTSD, is receiving initial funding to develop its products. . . . → Read More: Small Biz Grant Funds PTSD Diagnostic, Treatment

AI-Based Discovery Seeks Non-Opioid Pain Drugs

Neuron

A new initiative aims to find non-opioid treatments for chronic pain targeting specific nerve cells that initiate pain sensations. . . . → Read More: AI-Based Discovery Seeks Non-Opioid Pain Drugs